Outset medical Inc

Outset medical Inc

Outset medical Inc is a medical device company that develops, manufactures, and markets dialysis systems.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts encourage buying Outset Medical's stock with a target price of $5.4, indicating growth potential.

Average

Financial Health

Outset Medical is generating moderate revenue and cash flow, but its profit margins are relatively low.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring OM

At-Home Healthcare Stocks Explained | FDA Approval

At-Home Healthcare Stocks Explained | FDA Approval

The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.

Published: August 30, 2025

Explore Basket
Wearable Tech IP Wars: What Investors Should Know

Wearable Tech IP Wars: What Investors Should Know

Masimo's lawsuit against U.S. Customs, following a reversal of an import ban on Apple Watches, highlights the fierce competition over intellectual property in wearable health. This theme focuses on the medical technology companies and competitors poised to benefit from the ongoing patent battles in the lucrative health-monitoring device market.

Published: August 21, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Adoption Opportunity

The Tablo system aims to simplify dialysis delivery, which could support commercial adoption β€” though uptake depends on clinical acceptance and procurement cycles.

🌍

Global Demand Trends

Ageing populations and rising chronic kidney disease suggest structural demand for dialysis, yet reimbursement and regional regulation can strongly influence outcomes.

⚑

Execution Risks

Scaling manufacturing, navigating approvals and competing with larger players are key execution challenges; small-cap stocks can be particularly volatile.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

TMO

Thermo Fisher Scientific, Inc.

Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

ISRG

Intuitive Surgical, Inc.

A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties

Frequently asked questions